Search Results - "Goedee, H S"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Application of the 2021 EAN/PNS criteria for chronic inflammatory demyelinating polyneuropathy by Rajabally, Yusuf A, Afzal, Saadia, Loo, Lay Khoon, Goedee, HS

    “…BackgroundThe diagnostic value of new criteria of the European Academy of Neurology/Peripheral Nerve Society (EAN/PNS) for chronic inflammatory demyelinating…”
    Get full text
    Journal Article
  2. 2

    Instrumented assessment of lower and upper motor neuron signs in amyotrophic lateral sclerosis using robotic manipulation: an explorative study by Stikvoort García, D J L, Sleutjes, B T H M, Mugge, W, Plouvier, J J, Goedee, H S, Schouten, A C, van der Helm, F C T, van den Berg, L H

    “…Amyotrophic lateral sclerosis (ALS) is a lethal progressive neurodegenerative disease characterized by upper motor neuron (UMN) and lower motor neuron (LMN)…”
    Get full text
    Journal Article
  3. 3

    High resolution sonography in the evaluation of the peripheral nervous system in polyneuropathy - a review of the literature by Goedee, H. S., Brekelmans, G. J. F., van Asseldonk, J. T. H., Beekman, R., Mess, W. H., Visser, L. H.

    Published in European journal of neurology (01-10-2013)
    “…Clinical, laboratory and electrodiagnostic studies are the mainstay in the diagnosis of polyneuropathy. An accurate etiological diagnosis is of paramount…”
    Get full text
    Journal Article
  4. 4

    Diagnostic accuracy of nerve excitability and compound muscle action potential scan derived biomarkers in amyotrophic lateral sclerosis by Stikvoort García, D J L, Sleutjes, B, van Schelven, L J, Goedee, H S, van den Berg, L H

    Published in European journal of neurology (01-10-2023)
    “…The lack of reliable early biomarkers still causes substantial diagnostic delays in amyotrophic lateral sclerosis (ALS). The aim was to assess the diagnostic…”
    Get full text
    Journal Article
  5. 5

    Multifocal enlargement and increased vascularization of peripheral nerves detected by sonography in CIDP: A pilot study by Goedee, H.S, Brekelmans, G.J.F, Visser, L.H

    Published in Clinical neurophysiology (01-01-2014)
    “…Highlights • Sonography of the peripheral nervous system reveals multifocal nerve enlargement in the majority of chronic inflammatory demyelinating…”
    Get full text
    Journal Article
  6. 6

    Superficial temporal artery-middle cerebral artery bypass surgery in a pediatric giant intracranial aneurysm presenting as migraine-like episodes by Goedee, H. S, Depauw, P. R. A. M, vd Zwam, B, Temmink, A. H

    Published in Child's nervous system (01-02-2009)
    “…Introduction Aneurysms of the intracranial arteries in the pediatric population are reportedly rare. There is a male predominance, association with connective…”
    Get full text
    Journal Article
  7. 7

    A comparative study of brachial plexus sonography and magnetic resonance imaging in chronic inflammatory demyelinating neuropathy and multifocal motor neuropathy by Goedee, H. S., Jongbloed, B. A., Asseldonk, J.‐T. H., Hendrikse, J., Vrancken, A. F. J. E., Franssen, H., Nikolakopoulos, S., Visser, L. H., Pol, W. L., Berg, L. H.

    Published in European journal of neurology (01-10-2017)
    “…Background and purpose To compare the performance of neuroimaging techniques, i.e. high‐resolution ultrasound (HRUS) and magnetic resonance imaging (MRI), when…”
    Get full text
    Journal Article
  8. 8

    Clinical outcome of CIDP one year after start of treatment: a prospective cohort study by Bus, S. R. M., Broers, M. C., Lucke, I. M., Bunschoten, C., van Lieverloo, G. G. A., Adrichem, M. E., van Veen, R., Wieske, L., Lingsma, H. F., Goedee, H. S., van der Pol, W. L., van Schaik, I. N., Van Doorn, P. A., Jacobs, B. C., Eftimov, F.

    Published in Journal of neurology (01-02-2022)
    “…Objective To assess clinical outcome in treatment-naive patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Methods We included…”
    Get full text
    Journal Article
  9. 9
  10. 10

    T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination by Verstegen, Niels J M, Hagen, Ruth R, Kreher, Christine, Kuijper, Lisan H, Dijssel, Jet van den, Ashhurst, Thomas, Kummer, Laura Y L, Palomares Cabeza, Virginia, Steenhuis, Maurice, Duurland, Mariël C, Jongh, Rivka de, Schoot, C Ellen van der, Konijn, Veronique A L, Mul, Erik, Kedzierska, Katherine, van Dam, Koos P J, Stalman, Eileen W, Boekel, Laura, Wolbink, Gertjan, Tas, Sander W, Killestein, Joep, Rispens, Theo, Wieske, Luuk, Kuijpers, Taco W, Eftimov, Filip, van Kempen, Zoé L E, van Ham, S Marieke, ten Brinke, Anja, van de Sandt, Carolien E, vd Kooi, AJ, Raaphorst, J, Koos Zwinderman, AH, Löwenberg, M, Volkers, AG, D'Haens, GRAM, Takkenberg, RB, Spuls, PI, Bekkenk, MW, Musters, AH, Post, NF, Bosma, AL, Hilhorst, ML, Vegting, Y, Bemelman, FJ, Fernandez, L, Keijzer, S, Keijser, JBD, Cristianawati, O, Voskuyl, AE, Broens, B, Sanchez, AP, Nejentsev, S, Mirfazeli, ES, Rutgers, BA, de Leeuw, K, Horváth, B, Verschuuren, JJGM, Ruiter, AM, van Ouwerkerk, L, van der Woude, D, Allaart, RCF, Teng, YKO, Pieter van Paassen, PA, Busch, MH, Brusse, E, van Doorn, PA, Baars, MAE, Hijnen, DJ, Schreurs, CRG, van der Pol, WL, Goedee, HS, Els, CACM van, de Wit, J

    “…BackgroundMessenger RNA (mRNA) vaccines provide robust protection against SARS-CoV-2 in healthy individuals. However, immunity after vaccination of patients…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13